Literature DB >> 21413057

Prostate cancer metabolite quantification relative to water in 1H-MRSI in vivo at 3 Tesla.

Mary A McLean1, Tristan Barrett, Vincent J Gnanapragasam, Andrew N Priest, Ilse Joubert, David J Lomas, David E Neal, John R Griffiths, Evis Sala.   

Abstract

(1)H magnetic resonance spectroscopic imaging was performed on 16 men with suspected prostate cancer using an 8-channel external receive coil at 3 T. Choline and citrate (Cit) signals were measured in prostate lesions and normal-appearing peripheral zone as identified on T(2)-weighted images. Metabolites were quantified relative to unsuppressed water from a separately acquired magnetic resonance spectroscopic imaging dataset using LCModel. Validation experiments were also performed in a phantom containing physiological concentrations of choline, Cit, and creatine. In vitro, fair agreement between measured and true concentrations was observed, with the greatest discrepancy being a 35% underestimation of Cit. In vivo, one dataset was rejected for failure to meet the quality criterion of linewidth <15 Hz, and in 6 of 15 subjects, insufficient normal-appearing peripheral zone tissue was identified for study. Lesions were found to have higher choline and choline/Cit, and lower Cit, than normal-appearing peripheral zone. The smaller skew of data obtained using water normalization in comparison with metabolite ratios suggests potential usefulness in longitudinal tumor monitoring and in studies of treatment effects.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21413057     DOI: 10.1002/mrm.22703

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  8 in total

Review 1.  A decade in prostate cancer: from NMR to metabolomics.

Authors:  Elita M DeFeo; Chin-Lee Wu; W Scott McDougal; Leo L Cheng
Journal:  Nat Rev Urol       Date:  2011-05-17       Impact factor: 14.432

2.  Improved spatial localization in magnetic resonance spectroscopic imaging with two-dimensional PSF-Choice encoding.

Authors:  Shelley HuaLei Zhang; Stephan E Maier; Lawrence P Panych
Journal:  J Magn Reson       Date:  2018-03-03       Impact factor: 2.229

3.  The aging effect on prostate metabolite concentrations measured by 1H MR spectroscopy.

Authors:  Monika Dezortova; Filip Jiru; Antonin Skoch; Vaclav Capek; Zuzana Ryznarova; Viktor Vik; Milan Hajek
Journal:  MAGMA       Date:  2016-08-13       Impact factor: 2.310

Review 4.  Functional and molecular imaging of localized and recurrent prostate cancer.

Authors:  Kinzya Grant; Maria L Lindenberg; Haytham Shebel; Yuxi Pang; Harsh K Agarwal; Marcelino Bernardo; Karen A Kurdziel; Baris Turkbey; Peter L Choyke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-07       Impact factor: 9.236

5.  H HRMAS NMR Derived Bio-markers Related to Tumor Grade, Tumor Cell Fraction, and Cell Proliferation in Prostate Tissue Samples.

Authors:  Katarina Stenman; Pär Stattin; Hans Stenlund; Katrine Riklund; Gerhard Gröbner; Anders Bergh
Journal:  Biomark Insights       Date:  2011-03-14

Review 6.  Developments in proton MR spectroscopic imaging of prostate cancer.

Authors:  Angeliki Stamatelatou; Tom W J Scheenen; Arend Heerschap
Journal:  MAGMA       Date:  2022-04-20       Impact factor: 2.533

7.  Evaluation of short-TE (1)H MRSI for quantification of metabolites in the prostate.

Authors:  Meer Basharat; Maysam Jafar; Nandita M deSouza; Geoffrey S Payne
Journal:  NMR Biomed       Date:  2014-02-12       Impact factor: 4.044

8.  TE = 32 ms vs TE = 100 ms echo-time (1)H-magnetic resonance spectroscopy in prostate cancer: Tumor metabolite depiction and absolute concentrations in tumors and adjacent tissues.

Authors:  Meer Basharat; Geoffrey S Payne; Veronica A Morgan; Chris Parker; David Dearnaley; Nandita M deSouza
Journal:  J Magn Reson Imaging       Date:  2015-08-10       Impact factor: 4.813

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.